Standard BioTools Inc. (LAB)
Total Valuation
LAB has a market cap or net worth of $232.55 million. The enterprise value is $187.29 million.
Market Cap | 232.55M |
Enterprise Value | 187.29M |
Important Dates
The next estimated earnings date is Tuesday, November 7, 2023, after market close.
Earnings Date | Nov 7, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
LAB has 78.96 million shares outstanding. The number of shares has increased by 1.09% in one year.
Shares Outstanding | 78.96M |
Shares Change (YoY) | +1.09% |
Shares Change (QoQ) | -0.52% |
Owned by Insiders (%) | 2.79% |
Owned by Institutions (%) | 61.67% |
Float | 52.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.16 |
Forward PS | 4,697.48 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91
Current Ratio | 3.91 |
Quick Ratio | 3.36 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -17.78 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -22.00% |
Return on Capital (ROIC) | -35.70% |
Revenue Per Employee | $201,629 |
Profits Per Employee | -$160,906 |
Employee Count | 523 |
Asset Turnover | 0.28 |
Inventory Turnover | 2.64 |
Taxes
Income Tax | -79,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +142.86% in the last 52 weeks. The beta is 1.47, so LAB's price volatility has been higher than the market average.
Beta (1Y) | 1.47 |
52-Week Price Change | +142.86% |
50-Day Moving Average | 2.70 |
200-Day Moving Average | 2.12 |
Relative Strength Index (RSI) | 50.00 |
Average Volume (30 Days) | 252,350 |
Short Selling Information
The latest short interest is 2.74 million, so 3.47% of the outstanding shares have been sold short.
Short Interest | 2.74M |
Short Previous Month | 2.55M |
Short % of Shares Out | 3.47% |
Short % of Float | 5.22% |
Short Ratio (days to cover) | 10.81 |
Income Statement
In the last 12 months, LAB had revenue of $105.45 million and -$84.15 million in losses. Loss per share was -$1.06.
Revenue | 105.45M |
Gross Profit | 46.11M |
Operating Income | -84.18M |
Pretax Income | -84.23M |
Net Income | -84.15M |
EBITDA | -76.44M |
EBIT | -79.75M |
Loss Per Share | -$1.06 |
Balance Sheet
The company has $142.30 million in cash and $101.39 million in debt, giving a net cash position of $40.92 million or $0.52 per share.
Cash & Cash Equivalents | 142.30M |
Total Debt | 101.39M |
Net Cash | 40.92M |
Net Cash Per Share | $0.52 |
Equity / Book Value | -113.39M |
Book Value Per Share | -1.44 |
Working Capital | 136.23M |
Cash Flow
In the last 12 months, operating cash flow was -$61.61 million and capital expenditures -$3.87 million, giving a free cash flow of -$65.47 million.
Operating Cash Flow | -61.61M |
Capital Expenditures | -3.87M |
Free Cash Flow | -65.47M |
FCF Per Share | -$0.83 |
Margins
Gross margin is 43.73%, with operating and profit margins of -79.83% and -79.80%.
Gross Margin | 43.73% |
Operating Margin | -79.83% |
Pretax Margin | -79.88% |
Profit Margin | -79.80% |
EBITDA Margin | -72.49% |
EBIT Margin | -75.62% |
FCF Margin | -62.09% |
Dividends & Yields
LAB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -36.88% |
FCF Yield | -28.69% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.09% |
Shareholder Yield | -1.09% |
Analyst Forecast
The average price target for LAB is $4.00, which is 35.82% higher than the current price. The consensus rating is "Buy".
Price Target | $4.00 |
Price Target Difference | 35.82% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |